Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958888 · ClinicalTrials.gov registry record · NA
Visual Attention to Text and Pictorial Food Labels: An Eye Tracking Experiment
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT05958888: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT05958888 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05958888, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The goal of this study is to examine attention elicited by icon, text-only, and control front-of-package food labels. The study also aims to explore whether English language proficiency moderates the impact of icon vs. text-only labels on attention.
Primary Outcome
This outcome will be measured using eye tracking technology.
Interventions
- BEHAVIORAL Text only sodium label
- BEHAVIORAL Icon sodium label
- BEHAVIORAL Pictorial sodium label
- BEHAVIORAL Barcode label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2023-08-02 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
What the finished NCT05958888 record still lists
NCT05958888 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Text only sodium label is the first listed.
NCT05958888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05958888 about?
NCT05958888 is a clinical study titled "Visual Attention to Text and Pictorial Food Labels: An Eye Tracking Experiment". The goal of this study is to examine attention elicited by icon, text-only, and control front-of-package food labels. The study also aims to explore whether English language proficiency moderates the impact of icon vs. text-only labels on attention.
What is the current status of trial NCT05958888?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2023-08-02. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT05958888?
The interventions under investigation include: Text only sodium label (BEHAVIORAL), Icon sodium label (BEHAVIORAL), Pictorial sodium label (BEHAVIORAL), Barcode label (BEHAVIORAL).
Who is sponsoring clinical trial NCT05958888?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05958888's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI